Please login to the form below

Not currently logged in
Email:
Password:

clazakizumab

This page shows the latest clazakizumab news and features for those working in and with pharma, biotech and healthcare.

Sanofi's sarilumab beats Humira in head-to-head trial

Sanofi's sarilumab beats Humira in head-to-head trial

Other companies developing IL-6 inhibitors for RA include GlaxoSmithKline (GSK) and Janssen, whose sirukumab candidate is scheduled for filing later this year, and Alder Bio Pharmaceuticals which has clazakizumab in

Latest news

  • Positive data for BMS’ clazakizumab in arthritis Positive data for BMS’ clazakizumab in arthritis

    Bristol-Myers Squibb (BMS) could be adding another drug to its rheumatoid arthritis (RA) franchise after reporting encouraging phase IIb data on clazakizumab this week. ... Clazakizumab … provides promising remission data that will need to be further

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hanson Zandi

Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...

Latest intelligence

Playing Mind Games
To give a brief strong direction, we need to ascertain how the brand intends to win attention, how it will engage, what its call to action will be and how...
PM Society Digital Award Finalists
P&P are shortlisted for the ‘Craft in Film’ category at this year’s PM Society Digital Awards...
The Exhibition Hall: Past, Present and Future
As I sit here at another pharma conference, I start to reflect on how they have changed over the years....

Infographics